Kofke Anne E-Cambridge Health Alliance

Long on Language is an inclusive speech language pathology practice located in Cambridge, MA, dedicated to enhancing communication skills for individuals of all ages, from children to professional adults. With a commitment to supporting diverse backgrounds, they focus on empowering clients with a range of speech and language challenges, embracing cultural differences as vital to personal identity. Specializing in areas such as social language skills, verbal expression, and articulation, Long on Language offers tailored coaching to neurodivergent individuals and those facing communication difficulties. Their personalized approach fosters meaningful progress in clients' educational and social interactions, ensuring each session is engaging and responsive to individual needs. Generated from the website

Maya Hanelin is a Certified Internal Family Systems (IFS) Therapist based in Cambridge, MA, with over 20 years of experience supporting individuals, couples, and groups through various challenges, including relationship issues, trauma, and anxiety. She is dedicated to creating a healing space that fosters personal growth and the exploration of possibilities in clients' lives. Utilizing evidence-based modalities such as IFS and Intimacy From The Inside Out (IFIO), Maya aims to facilitate a deeper understanding of the self and its inner parts, promoting healing through collaboration and trust. Her compassionate approach has transformed the lives of many, making her a well-respected figure in the field of therapy. Generated from the website

Obsidian Therapeutics Inc, based in Cambridge, MA, is at the forefront of precision cell and gene therapy, utilizing its proprietary cytoDRIVE platform to engineer regulated therapeutic proteins. The company is dedicated to pioneering the next generation of engineered therapeutics to address critical patient needs. With a focus on innovative solutions, Obsidian is advancing its lead clinical program, OBX115, an engineered TIL cell therapy targeting advanced melanoma. The company’s commitment to collaboration and urgency drives its mission to improve patient outcomes through cutting-edge science and technology. Generated from the website